15.05.2012

Telomerase Gene Therapy Slows Ageing

Gene therapy allows older mice to live longer, healthier lives report researchers in a new study published in EMBO Molecular Medicine. Mice that received a single gene-therapy treatment to deliver telomerase to different cells in the body showed drastic improvements in health, fitness and longevity. Telomerase is an enzyme that helps to maintain the physical integrity of the ends of chromosomes. more11.05.2012

The European Lab Automation Conference and Exhibition 2012

Staying abreast of the latest advances in technology and ensuring that the most effective, ­up-to-date automation techniques are being employed can be challenging. Attending conferences and exhibitions throughout the year provides scientists not only the opportunity to share their experiences and to network with researchers in their field, but delegates can also discuss their challenges with equipment manufacturers who can often help to tailor a solution to meet their automation needs. more08.05.2012

Angewandte Chemie: Test Result Written in Blood

Angewandte Chemie Int. Edition: In the book "Harry Potter and the Chamber of Secrets" by J. K. Rowling, Harry writes a question in Tom Riddle's diary-and a written answer appears. Australian researchers were inspired by the idea of paper that writes on itself. Now they have introduced a blood test that indicates blood type in plain text. more04.05.2012

Karolinska Institutet: Drug Delivery via the Skin

A research team at Karolinska Institutet has succeeded in describing the structure and function of the outermost layer of the skin - the stratum corneum - at a molecular level. This opens the way not only for the large-scale delivery of drugs via the skin, but also for a deeper understanding of skin diseases. more03.05.2012

Sartorius Stedim Biotech and c-LEcta Sign Sales Agreement

Sartorius Stedim Biotech and the biotechnology specialist c-LEcta, announce the signing of a worldwide sales and distribution agreement for c-LEcta's proprietary Serratia marcescens nuclease for biopharmaceutical applications. The German company specializes in the development of customized enzymes and production strains for industrial applications. Based on this agreement, customized endonuclease will now be
available under the product name "Denarase" through all regular Sartorius Stedim Biotech sales channels. more02.05.2012

SLAS Now Accepting Abstract Submissions for Presentations at 2nd SLAS Conference and Exhibition

The Society for Laboratory Automation and Screening (SLAS) is now accepting abstract submissions for podium and poster presentations at SLAS2013, the Second Annual SLAS Conference and Exhibition, January 12-16, at the Gaylord Palms Resort and Convention Center in Orlando, FL, USA. more27.04.2012

Sartorius Stedim Biotech Launches Initiative to Enhance Supply Chain Security

Sartorius Stedim Biotech (SSB) has substantially extended its supply chain security practices. By launching a comprehensive initiative, SSB is anticipating the emerging requirements of the biopharmaceutical industry for "end-to-end" security across the entire supply chain spectrum, as stressed by leading regulatory bodies like the FDA and related special interest groups. These groups have cited that each link in the supply chain poses a potential threat to a drug's security and that suppliers should be viewed as an extension of a biopharmaceutical manufacturer. more27.04.2012

Cloud Computing and Genomics and How They can be Combined

Cloud computing and genomic research are two of the most noteworthy advancements in medicine and technology. These two advancements have been on separate pathways, each having little to do with the other - until now. Today, medical research institutions are partnering with large software and hardware technology vendors to leverage cloud computing to tackle some of the most challenging issues facing big science; in particular, cancer treatment. more26.04.2012

Domino: Nanotechnology for Lab-on-a-Chip

The Domino technology uses a plastic chip that can perform 20 genetic tests from a single drop of blood. This technology has been developed by researchers of the University of Alberta. Read the full press release here. Video courtesy of Alex Stickel   more26.04.2012

Domino: Nanotechnology for Lab-on-a-Chip

Domino, a new nanotechnology developed by a research team from the University of Alberta, has the potential to revolutionize point-of-care medicine. You wouldn't know it from appearances, but a metal cube the size of a toaster is capable of performing the same genetic tests as most fully equipped modern laboratories - and in a fraction of the time. more